Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Marker Band Swager Offers Touch Screen

December 8, 2010 5:59 am | Interface Catheter Solutions | Product Releases | Comments

Interface Catheter Solutions upgrades to the MBS-200; marker band swaging equipment includes touch screen with easy to operate user interface and clear catheter insertion guide for improved swaging alignment.

Linear Actuators Have Extended Stroke of 20 mm

December 8, 2010 5:53 am | Product Releases | Comments

Haydon Kerk Motion Solutions Inc, a leading manufacturer of precision linear motion products, offers the 19000 Series, 20-mm captive linear actuator in a variety of stroke lengths.

Linear Actuators Available With Class I, Division 2 Certification

December 8, 2010 5:33 am | Product Releases | Comments

Exlar’s GSX and GSM linear actuators now offer Class I, Division 2 Certification, expanding the company’s actuator line for operation in hazardous environments.

Advertisement

Euthymics presents phase II data for EB-1010 in major depression at ACNP annual meeting

December 8, 2010 5:33 am | by EurekAlert | News | Comments

(BioCom Partners) Euthymics Bioscience, Inc. presents Phase II clinical data demonstrating that its lead product candidate EB-1010, a next-generation antidepressant (unbalanced triple reuptake inhibitor), is effective for treating major depressive disorder, and improved measures of...

TOPICS:

Class I Medical Device Recall: Penumbra System Reperfusion Catheter 032

December 8, 2010 5:30 am | by U.S. Food & Drug Administration | News | Comments

Reason for Recall: As a result of a manufacturing error, mid-shaft joint failures were occurring in some Reperfusion Catheters 032 produced from lot F15020.

TOPICS:

Drivers Meet Rigorous Demands for Environment Friendly LED Lighting Solutions

December 8, 2010 5:21 am | Product Releases | Comments

With the release of AMLD-Z, Aimtec launches the third series in its line of DC/DC LED Drivers. Offered in DIP24 packages, the AMLD-Z are feature rich LED drivers that meet the rigorous demands...

Catabasis Pharmaceuticals adds $14.5M to Series A financing

December 8, 2010 4:33 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Catabasis Pharmaceuticals Inc., a Cambridge biopharmaceutical company focused on inflammatory and metabolic diseases, has raised $14.5 million in a second tranche of a Series A funding round.

Florida Metrology To Distribute OASIS Inspection Systems

December 8, 2010 4:33 am | by Bio-Medicine.Org | News | Comments

MIDDLETOWN, Del., Dec. 8, 2010 /- George Products Company, Inc. has announced the addition of Florida Metrology as the newest distributor of its OASIS Inspection Systems. Florida Metrology, based in Jupiter, will distribute the product throughout southeast Florida. OASIS Inspection...

TOPICS:
Advertisement

For the Treatment of Ovarian Cancer, Pegylated Liposomal Doxorubicin/Carboplatin Will Replace Paclitaxel/Carboplatin as the Standard Second-Line Treatment for Platinum Sensiti...

December 8, 2010 4:33 am | by Bio-Medicine.Org | News | Comments

BURLINGTON, Mass., Dec. 8, 2010 /- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that although platinum-based treatment will continue to be the standard of care for first- and second-line treatment of...

TOPICS:

Government Regulation of Drug Prices will Increase in Both Mature and Emerging Markets, Including Markets that Traditionally Play a Limited Role in Pharmaceutical Pricing

December 8, 2010 4:33 am | by Bio-Medicine.Org | News | Comments

BURLINGTON, Mass., Dec. 8, 2010 /- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the pharmaceutical industry must prepare itself for an increasingly draconian drug pricing environment. While governments in...

TOPICS:

Otonomy Appoints David A. Weber, Ph.D., Chief Executive Officer

December 8, 2010 4:32 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Dec. 8, 2010 /- Otonomy, Inc . announced today that David A. Weber, Ph.D. , has joined the company as president, CEO and member of the Board of Directors. Jay Lichter, Ph.D., managing director of Avalon Ventures, co-founder of Otonomy and CEO since its inception, will continue...

TOPICS:

CareFusion Launches Respiratory Airway Adapter to Improve Patient Safety and Reduce Hospital Costs

December 8, 2010 4:32 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Dec. 8, 2010 /- CareFusion (NYSE: CFN ), a leading, global medical device company, today announced the launch of Verso™ 90 adapter, a component that enables uninterrupted access to a ventilated patient's airway without having to disconnect the patient from the ventilator....

TOPICS:

Texas-Based Healthcare Delivery System Expands Utilization of Streamline Health Document Workflow Solutions

December 8, 2010 4:32 am | by Bio-Medicine.Org | News | Comments

CINCINNATI, Dec. 8, 2010 /- Streamline Health Solutions, Inc. (Nasdaq: STRM ), a leading provider of document workflow solutions for hospitals, today announced that one of the largest faith-based, nonprofit healthcare delivery systems in the United States, will implement Streamline...

TOPICS:

Winner Medical Reports Fourth Quarter and Fiscal 2010 Results

December 8, 2010 4:32 am | by Bio-Medicine.Org | News | Comments

SHENZHEN, China, Dec. 8, 2010 /PRNewswire-Asia-FirstCall/ -- Fourth - Quarter 2010 Highlights Revenue increased by 2.1% over Q4 FY09 to $28.2 million Gross profit increased by 5.8% over Q4 FY09 to $8.8 million Net income increased by 5.9% over Q4 FY09 to $3.1 million with EPS of $0.13...

TOPICS:

Sofie Biosciences Raises $2M to Support Development of Diagnostic Imaging Agents and Devices

December 8, 2010 4:32 am | by Bio-Medicine.Org | News | Comments

CULVER CITY, Calif., Dec. 8, 2010 /- Sofie Biosciences, a developer of agents and devices for the molecular imaging of disease, announced today the closing of an additional $2 million from new and existing investors. Funds will be used for the development of new PET imaging agents and for...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading